Announcements Trials
Browse Landscape

Phase

Phase 2 73Phase 1 69Phase 1/2 27Phase 3 8Phase NA 6Phase EARLY_PHASE1 3Phase 4 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 3Sarcoma 1Other solid neoplasm 1Head & Neck 1

Conditions

Solid Tumors 1Sarcoma 1Prostatic Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Interventional × temsirolimus × Clear all
NCT04199026 2026-02-19

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

M.D. Anderson Cancer Center

Phase NA Recruiting
20 enrolled
Sarcoma

Sarcoma

NCT01326468 2025-09-25

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Thomas Jefferson University

Phase NA Withdrawn
Head & Neck

Head and Neck Neoplasms

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

AVEO Pharmaceuticals, Inc.

Phase NA Terminated
225 enrolled 7 charts
Other solid neoplasm

Solid Tumors

NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown
100 enrolled
Genitourinary

Kidney Neoplasms

NCT01404104 2016-07-27

Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma

St. Joseph's Healthcare Hamilton

Phase NA Completed
11 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00235794 2007-12-27

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Wyeth is now a wholly owned subsidiary of Pfizer

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡